No Time to Die—How Islets Meet Their Demise in Transplantation
Cells · 03.03.2023 · 12 (5) · 796
DOI: 10.3390/cells12050796 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 03.03.2023. Verfasst von Atharva Kale und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Transplant and Renal Research, Westmead Institute for Medical Research, Westmead, NSW 2145, Australia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Islets of Langerhans Transplantation, Insulin-Secreting Cells, Hypoglycemia. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Sydney and Juvenile Diabetes Research Foundation, National Health and Medical Research Council.
Abstract (Originalsprache)
Islet transplantation represents an effective treatment for patients with type 1 diabetes mellitus (T1DM) and severe hypoglycaemia unawareness, capable of circumventing impaired counterregulatory pathways that no longer provide protection against low blood glucose levels. The additional beneficial effect of normalizing metabolic glycaemic control is the minimisation of further complications related to T1DM and insulin administration. However, patients require allogeneic islets from up to three donors, and the long-term insulin independence is inferior to that achieved with solid organ (whole pancreas) transplantation. This is likely due to the fragility of islets caused by the isolation process, innate immune responses following portal infusion, auto- and allo-immune-mediated destruction and β-cell exhaustion following transplantation. This review covers the specific challenges related to islet vulnerability and dysfunction that affect long-term cell survival following transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Transplant and Renal Research, Westmead Institute for Medical Research, Westmead, NSW 2145, Australia.
- Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2006, Australia.
- Renal and Transplant Unit, Westmead Hospital, Westmead, NSW 2145, Australia.
ORCID-Profile: Atharva Kale
Förderung
- University of Sydney and Juvenile Diabetes Research Foundation
- National Health and Medical Research Council
Zitieren
APA
Kale, A., & Rogers, N. M. (2023). No Time to Die—How Islets Meet Their Demise in Transplantation. Cells, 12(5), 796. https://doi.org/10.3390/cells12050796
Vancouver
Kale A, Rogers NM. No Time to Die—How Islets Meet Their Demise in Transplantation. Cells. 2023;12(5):796. doi:10.3390/cells12050796
BibTeX
@article{Kale2023,
author = {Kale, Atharva and Rogers, Natasha M},
title = {No Time to Die—How Islets Meet Their Demise in Transplantation},
journal = {Cells},
year = {2023},
volume = {12},
number = {5},
pages = {796},
doi = {10.3390/cells12050796}
}
EUVIMED